← AI, data and analytics companies

    Absci: company profile, size and contacts

    absci.comActiveFor profit

    Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

    Employees
    101-250
    Founded
    2011
    Total raised
    $324.3M
    Monthly visits
    98,008

    Company facts

    Website
    absci.com
    Location
    West Coast, Western US
    Employees
    101-250
    Founded
    2011 (15 years ago)
    Categories
    Artificial Intelligence (AI), Biopharma, Biotechnology, Life Science
    Company type
    For profit
    Listing
    Public (NASDAQ:ABSI)
    Industry code (NAICS)
    5415 Computer systems design and related services; 5182 Computing infrastructure providers and data processing
    Industry code (SIC)
    7374 Computer processing and data preparation; 7371 Computer programming services

    Founder

    • Sean McClainFounder · Absci

    Absci was founded in 2011 by Sean McClain.

    Funding

    Total raised
    $324.3M
    Funding rounds
    11
    Latest round
    Post ipo equity, 2024-02
    Investors
    23
    Lead investors
    8
    Acquisitions made
    2

    Web and app presence

    Monthly website visits
    98,008
    Global traffic rank
    #374,945

    How Absci compares

    • Size: Absci has more employees than 75% of the 536 ai, data and analytics companies in our directory that report it.
    • Age: Absci is older than 59% of the 518 ai, data and analytics companies in our directory that report it.
    • Web traffic: Absci gets more monthly website visits than 93% of the 517 ai, data and analytics companies in our directory that report it.

    545 ai, data and analytics companies are in the directory, 77 of them in the same 101-250 employee range and 6 based in West Coast.

    Growth outlook

    • Trend: Growing
    • Direction: Growing
    • Confidence: High

    Absci reported its business updates and financial results for the fourth quarter and full year 2023. The company successfully completed an $86 million oversubscribed public offering. Absci's lead AI-designed candidate is set to head for the clinic in 2025.

    What Absci says about itself

    “Absci is a clinical-stage biopharmaceutical company advancing innovative therapeutics with generative AI.” absci.com

    Absci in short

    Founded in 2011, Absci works in artificial intelligence (ai), biopharma and biotechnology from West Coast and has 101-250 employees. It has raised $324.3 million over 11 rounds and its website drew about 98,008 visits in the latest month measured.

    Frequently asked questions

    What does Absci do?
    Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
    When was Absci founded?
    Absci was founded in 2011, so it is about 15 years old.
    How many employees does Absci have?
    Crunchbase lists Absci in the 101-250 employee range.
    Where is Absci based?
    Absci is listed under West Coast, Western US.
    Has Absci raised funding?
    Crunchbase records $324.3M raised across 11 funding rounds, most recently post ipo equity in 2024-02.
    How do I find email addresses at Absci?
    Search the domain absci.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in AI, data and analytics companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.